The application of complex psa and its relative indexes in the detection of prostate cancer

Chinese-German Journal of Clinical Oncology

Volumn 1, Issue 4, 2002, Pages 233-237

  Chen, Zhaohui ^a   Zhao, Jun ^a   Wu, Jianmin ^a   Xiao, Chuanguo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Complex PSA; Diagnosis; Prostate cancer

Indexed keywords

EID: 36849036609     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/BF02838441     Document Type: Article

References (12)

1. Brawer MK, Meyer GE, Letran JL, et al. Measuremmt of comptexed PSA improves specificity for early detection of prostate cancer. Urology, 1998, 52 : 372-378.
2. Maeda H, Arai Y, Aoki Y, et al. Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer. Urology, 1999, 54 : 225-228.
3. Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA, 1993, 270:860-864.
4. Peter J, Unverzagt C, Hoesel W. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha( 1 )-antichymotrypsin (PSA-ACT). Clin Chem, 2000, 46:474-482.
5. Oesterling JE, Jacobsen SJ, Klee GG, et al. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol, 1995, 154:1090-1095.
6. Tanguay S, Begin LR, Elhilali MM, et al. Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology, 2002, 59:261-265.
7. Miller MC, O' Dowd GJ, Partin AW, et al. Contemporary use of eomplexed PSA and calculated percent free PSA for early detection of prostare cancer: impact of changing disease demographics. Urology, 2001, 57: 1105-1111.
8. Stephan C, Jung K, Brux B, et al. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubie prostatectomy: proof of new complex fornfing of PSA after release into circulation. Urology, 2000, 55 : 560-563.
9. Pennek J, Rittenhouse HG, Chan DW, et al. The use of percent free prostete specific antigen for staging clinically localized prostate cancer. J Urol, 1998, 159:1238-1242.
10. Mitchell ID, Croal BL, Dickie A, et al. A prospective study to evaluate the role of eomplexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. J Urol, 2001, 165 : 1549-1553.
11. Lynn NN, Collins GN, O' Reilly PH, et al. Prostatic manipulation has a minimal effect on complexed prostate-specific antigen levels. BJU Int, 2000, 86 : 65-67.
12. Basso D, Fogar P, Piva MG, et al. Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when? Urology, 2000, 55:710-715.